CSI Dry Eye Innovations Unveils New Brand Identity and Secures Patent for AI-Supported Clinical Decision Platform
Wednesday, January 28 2026 | 15 h 30 min | News
CSI Dry Eye Innovations has announced a significant brand evolution alongside the issuance of a new patent for its flagship platform, CSI Dry Eye Software. The developments mark a strategic milestone for the company as it positions itself for long-term growth in the increasingly complex field of dry eye management.
The introduction of CSI Dry Eye Innovations as a parent brand establishes a future-focused brand architecture that will encompass both existing and forthcoming solutions. Within this structure, CSI Dry Eye Software remains the company’s core product and is now protected by a newly issued patent covering its underlying clinical decision-support framework.
According to the company, the rebrand reflects its evolution from a single-product provider into a broader digital partner for dry eye care, with an emphasis on consistency, clinical rigor, and evidence-based decision support.
Patent Protects Structured Clinical Reasoning Framework
The newly issued patent safeguards the proprietary clinical reasoning process embedded within CSI Dry Eye Software. Unlike tools that rely on individual test results or basic data aggregation, the platform integrates multiple dry eye indicators to assess subtype and severity, generating ranked and explainable treatment pathways to support clinician decision-making.
Importantly, the software is designed to support, not replace, clinical judgment. It does not diagnose autonomously or automate care decisions, but instead provides a standardized, evidence-based structure intended to help clinicians navigate the multifactorial nature of dry eye disease.
“Dry eye is not a single disease. It is a complex, multifactorial condition that requires thoughtful clinical reasoning,” said Dr. Ahmed Al-Ghoul, MD, Founder of CSI Dry Eye Innovations. “This patent recognizes the importance of structured, explainable decision support, not automation, in helping clinicians deliver consistent, high-quality dry eye care.”
A Brand Aligned with the Future of Dry Eye Care
The launch of CSI Dry Eye Innovations also includes a refreshed visual identity, clearer messaging around the company’s role in dry eye care, and a new website currently in development. The rebrand signals continued investment in platform capabilities, responsible use of AI, and tools designed to evolve alongside clinical best practices.
“At its core, this brand represents where CSI is headed,” said Lisa Rickards, CEO of CSI Dry Eye Innovations. “Dry eye is a rapidly evolving and increasingly complex condition, and our focus is on building intuitive, clinically structured tools that help clinicians deliver consistent, efficient, and confident care.”
CSI Dry Eye Innovations is a software company focused on supporting eye care professionals through AI-supported clinical decision tools, led by its flagship CSI Dry Eye Software platform.
Click HERE for the full press release.
Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!
